Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

While companies haven’t disclosed the exact terms of the settlements, Medtronic has begun educating physicians about the shortcomings of its devices and providing QR codes on its devices that ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

GALWAY, Ireland, Nov. 5, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...